Get Fit Bharat

Tag: Pilates

HomePilates

Litton Das has been appointed as Bangladesh's captain for the upcoming three-match T20I series against the West Indies, marking the first time he will lead the side for an entire series. Litton previously stepped in as captain for a one-off match against New Zealand in April 2021. Several players like batting allrounder Shamim Hossain, who …

On 4 October 2024, TF Bank AB (publ) (”TF Bank” or the ”Bank”) announced that the Bank entered into a share purchase agreement (the “Share Purchase Agreement”) with Alektum Holding AB (publ) (”Alektum Holding”) and Erik Selin Fastigheter Aktiebolag (”Erik Selin Fastigheter”) regarding a transfer of a majority stake in …

Pep Guardiola sent shockwaves through the football world by revealing he does not intend to coach another club after concluding his illustrious tenure with Manchester City, citing a lack of energy for a fresh start. Echoing sentiments once expressed by his former Liverpool rival, J¼rgen Klopp, Guardiola hinted at the possibility of managing a national …

Tel Aviv, Israel (December 10, 2024) – Eco Wave Power Global AB (publ) (Nasdaq: WAVE) (“Eco Wave Power” or the “Company”), a leading innovator in onshore wave energy technology, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 300,000 American Depositary Shares …

Los Angeles, United States:  Material, a leading insights, marketing and technology company, is pleased to announce it is the recipient of the Splash Award in the “Education” category for work with INSEAD – The Business School for the World® and runner-up in the “Corporate” category for work with Stuff Limited. The …

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES TO DISTRIBUTE THIS ANNOUNCEMENT. EQL Pharma AB (publ) (the “Company” or “EQL”) today announces …

San Mateo, Calif., United States:   5-year follow-up from SEQUOIA study demonstrated treatment with BRUKINSA reduced the risk of progression or death by 71% compared to bendamustine-rituximab in patients with treatment-naïve CLL, further solidifying its position as the leader in new patient starts in both frontline and relapsed/refractory (R/R) CLL with …

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES TO DISTRIBUTE THIS ANNOUNCEMENT. EQL Pharma AB (publ) (the “Company” or “EQL”) today announces …